Hambrecht & Quist Capital Management as of March 31, 2011
Portfolio Holdings for Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management holds 89 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 4.0 | $24M | 564k | 42.44 | |
| Dendreon Corporation | 3.6 | $22M | 575k | 37.43 | |
| WellPoint | 3.3 | $20M | 283k | 69.79 | |
| Illumina (ILMN) | 2.9 | $17M | 249k | 70.07 | |
| Alexion Pharmaceuticals | 2.8 | $17M | 169k | 98.68 | |
| Aetna | 2.6 | $16M | 418k | 37.43 | |
| Mylan | 2.5 | $15M | 670k | 22.67 | |
| Amgen (AMGN) | 2.5 | $15M | 278k | 53.45 | |
| Hologic (HOLX) | 2.5 | $15M | 663k | 22.20 | |
| Teva Pharmaceutical Industries (TEVA) | 2.3 | $14M | 273k | 50.17 | |
| Celgene Corporation | 2.3 | $14M | 234k | 57.53 | |
| Perrigo Company | 2.2 | $13M | 165k | 79.52 | |
| Warner Chilcott Plc - | 2.1 | $13M | 540k | 23.28 | |
| Shire | 2.0 | $12M | 138k | 87.10 | |
| Human Genome Sciences | 2.0 | $12M | 435k | 27.45 | |
| Alkermes | 1.9 | $12M | 897k | 12.95 | |
| PerkinElmer (RVTY) | 1.9 | $11M | 431k | 26.27 | |
| Cubist Pharmaceuticals | 1.8 | $11M | 428k | 25.24 | |
| Elan Corporation | 1.8 | $11M | 1.6M | 6.88 | |
| Laboratory Corp. of America Holdings | 1.8 | $11M | 116k | 92.13 | |
| Kinetic Concepts | 1.8 | $11M | 193k | 54.42 | |
| Life Technologies | 1.7 | $10M | 194k | 52.42 | |
| Incyte Corporation (INCY) | 1.7 | $10M | 632k | 15.85 | |
| Medco Health Solutions | 1.7 | $10M | 179k | 56.16 | |
| Forest Laboratories | 1.7 | $10M | 308k | 32.30 | |
| IDEXX Laboratories (IDXX) | 1.6 | $9.8M | 127k | 77.22 | |
| Akorn | 1.6 | $9.6M | 1.7M | 5.77 | |
| Align Technology (ALGN) | 1.4 | $8.4M | 411k | 20.48 | |
| CVS Caremark Corporation (CVS) | 1.4 | $8.3M | 242k | 34.32 | |
| Amarin Corporation | 1.4 | $8.1M | 1.1M | 7.30 | |
| Genzyme Corporation | 1.3 | $7.9M | 104k | 76.15 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $7.8M | 1.0M | 7.59 | |
| Pharmaceutical Product Development | 1.3 | $7.7M | 276k | 27.71 | |
| Baxter International (BAX) | 1.2 | $7.4M | 138k | 53.77 | |
| Alere | 1.2 | $7.5M | 191k | 39.14 | |
| Charles River Laboratories (CRL) | 1.2 | $7.4M | 193k | 38.38 | |
| McKesson Corporation (MCK) | 1.1 | $6.7M | 85k | 79.05 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.1 | $6.5M | 64k | 100.16 | |
| Seattle Genetics | 1.0 | $5.8M | 372k | 15.57 | |
| Celera Corporation | 0.9 | $5.6M | 692k | 8.11 | |
| Salix Pharmaceuticals | 0.9 | $5.3M | 150k | 35.03 | |
| Quest Diagnostics Incorporated (DGX) | 0.9 | $5.2M | 90k | 57.72 | |
| Cephalon | 0.8 | $5.1M | 67k | 75.78 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $5.0M | 90k | 55.56 | |
| Allergan | 0.8 | $4.9M | 69k | 71.01 | |
| PAREXEL International Corporation | 0.8 | $4.8M | 194k | 24.90 | |
| Ironwood Pharmaceuticals (IRWD) | 0.8 | $4.5M | 325k | 14.00 | |
| EXACT Sciences Corporation (EXAS) | 0.8 | $4.5M | 612k | 7.36 | |
| Affymetrix | 0.7 | $4.4M | 842k | 5.21 | |
| Impax Laboratories | 0.7 | $4.4M | 173k | 25.45 | |
| Bruker Corporation (BRKR) | 0.7 | $4.4M | 213k | 20.85 | |
| Momenta Pharmaceuticals | 0.7 | $4.3M | 270k | 15.85 | |
| Intellipharmaceuticsintl Inc C | 0.7 | $4.2M | 1.6M | 2.71 | |
| Gen-Probe Incorporated | 0.6 | $3.8M | 58k | 66.36 | |
| Cadence Pharmaceuticals | 0.6 | $3.6M | 387k | 9.21 | |
| Inhibitex | 0.6 | $3.5M | 970k | 3.62 | |
| Acorda Therapeutics | 0.6 | $3.5M | 150k | 23.20 | |
| Pharmasset | 0.5 | $3.2M | 41k | 78.70 | |
| Auxilium Pharmaceuticals | 0.5 | $3.1M | 144k | 21.47 | |
| St. Jude Medical | 0.5 | $3.1M | 60k | 51.25 | |
| Santarus | 0.5 | $3.0M | 876k | 3.42 | |
| Geron Corporation (GERN) | 0.5 | $2.9M | 567k | 5.05 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $2.7M | 41k | 67.02 | |
| Onyx Pharmaceuticals | 0.5 | $2.7M | 77k | 35.19 | |
| Ariad Pharmaceuticals | 0.4 | $2.6M | 344k | 7.52 | |
| Amylin Pharmaceuticals | 0.4 | $2.5M | 216k | 11.37 | |
| Watson Pharmaceuticals | 0.4 | $2.4M | 43k | 56.00 | |
| XenoPort | 0.4 | $2.4M | 397k | 5.93 | |
| Adolor Corporation (ADLR) | 0.4 | $2.3M | 1.6M | 1.41 | |
| ISIS Pharmaceuticals | 0.4 | $2.2M | 243k | 9.04 | |
| Medivation | 0.4 | $2.2M | 120k | 18.64 | |
| Addus Homecare Corp (ADUS) | 0.4 | $2.2M | 432k | 5.01 | |
| Affymax (AFFY) | 0.3 | $2.1M | 352k | 5.87 | |
| Somaxon Pharmaceuticals | 0.3 | $2.1M | 746k | 2.83 | |
| Cooper Companies | 0.3 | $1.8M | 26k | 69.43 | |
| UnitedHealth (UNH) | 0.3 | $1.6M | 36k | 45.21 | |
| Danaher Corporation (DHR) | 0.3 | $1.6M | 31k | 51.89 | |
| Boston Scientific Corporation (BSX) | 0.3 | $1.6M | 218k | 7.19 | |
| Medtronic | 0.3 | $1.5M | 39k | 39.36 | |
| Zimmer Holdings (ZBH) | 0.3 | $1.5M | 25k | 60.54 | |
| Express Scripts | 0.2 | $1.5M | 27k | 55.62 | |
| STAAR Surgical Company (STAA) | 0.2 | $1.4M | 252k | 5.57 | |
| Nektar Therapeutics | 0.2 | $1.4M | 149k | 9.47 | |
| OncoGenex Pharmaceuticals | 0.2 | $1.4M | 93k | 15.34 | |
| Palomar Medical Technologies | 0.2 | $1.3M | 88k | 14.85 | |
| Cornerstone Therapeutics | 0.2 | $1.2M | 174k | 6.62 | |
| Corcept Therapeutics Incorporated (CORT) | 0.2 | $1.1M | 250k | 4.25 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $896k | 94k | 9.57 | |
| Telik (TELK) | 0.1 | $847k | 941k | 0.90 |
